Last reviewed · How we verify

NCT03843073

Connected Catheter- Safety and Effectiveness Study

Terminated NA Last updated 23 November 2021
What this trial tests

NA trial testing Connected Urinary Catheter in Urinary Retention in 9 participants. Terminated before completion.

Timeline
16 October 2020
Primary endpoint
23 March 2021
6 April 2021

Quick facts

Lead sponsorSpinal Singularity
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment9
Start date16 October 2020
Primary completion23 March 2021
Estimated completion6 April 2021
Sites9 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Spinal Singularity

Who can join

18 and older, male only, with Urinary Retention or Neurogenic Bladder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Connected Catheter is a fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization. It is a sterile, extended-use device that resides fully internally to the male lower urinary tract for an intended use life of up to 7 days per catheter.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urinary Retention

Currently open trials in the same condition.

Other Spinal Singularity trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03843073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing